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Abstract 
Background: We evaluated whether the administration of sildenafil in children undergoing 
TCPC operation shortened the interval from the operation to the removal of the pleural and 
peritoneal drains. 
Methods: We retrospectively reviewed the data of 122 patients who had undergone the 
TCPC operation between 2004 and 2014. Patients were divided into two groups on the basis 
of their treatments. Sildenafil was orally administered preoperatively in the morning of the 
procedure or within 24 hours after the TCPC operation to the sildenafil group (n=48), which 
was compared to a control group (n=60). Fourteen patients were excluded from the study. 
Results: The primary outcome measure was time from the operation to the removal of the 
drains. The study groups had similar demographics. The median [interquartile range] time to 
removal of drains (sildenafil group 11 [8–19] vs. control group 11 [7–16] days, P=0.532) was 
comparable between the groups. The median [interquartile range] fluid balance on the first 
postoperative day was significantly higher (P=0.001) in the sildenafil group compared with 
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controls (47 [12–103] vs. 7 [-6–67] ml/kg). The first postoperative day fluid balance was a 
significant predictor for a prolonged need for drains in the multivariate analysis. 
Conclusions: Sildenafil administration, preoperatively or within 24 hours after the TCPC 
operation, did not reduce the required time for pleural and peritoneal drains but was 
associated with a significantly higher positive fluid balance. 
 
Editorial Comment 
In this very special surgical cohort, children in staged surgical palliative interventions for their 
congenital univentricular heart malformation, there is a late step with a total cavopulmonary 
connection.  One challenge in this cohort is pleural and peritoneal effusions.  In this 
retrospective analysis, treatment with sildenafil was associated with less time postoperatively 
where pleural and peritoneal effusions require drainage.  We remember our cherished friend 
and editor for this journal Pertti Suominen, who contributed to this work and is a posthumous 
author. 
 
Introduction 
The total cavopulmonary connection (TCPC) operation is the last stage in the palliative 
treatment of patients with a univentricular heart malformation. Prolonged pleural and 
peritoneal effusion, however, remains a significant source of morbidity after the TCPC 
operation.1,2 High preoperative pulmonary artery pressure is a risk factor for prolonged 
pleural effusion.3 Sildenafil has been used in the treatment of pulmonary hypertension. 
Sildenafil reduces pulmonary vascular resistance and the transpulmonary gradient, which 
could,  in theory,  decrease pleural and peritoneal effusions after the TCPC operation.4 
Therefore, in 2006, our institution started the administration of sildenafil after the TCPC 
operation for occasional patients and usually later than 24 hours after operation, and since 
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2009, the majority of the patients received their first dose of sildenafil preoperatively in the 
morning of the operation. However, the benefits of sildenafil have been controversial in the 
two recent retrospective Fontan series.5,6 
Our aim in this study was to analyze the effect of prophylactic sildenafil on pleural and 
peritoneal effusion during the first postoperative day (POD) after TCPC surgery. We 
hypothesized that prophylactic sildenafil administration would result in decreased pleural and 
peritoneal effusions, and earlier removal of drains. 
 
Methods 
This retrospective study was performed in the Children’s Hospital of Helsinki University 
Hospital, which is a tertiary care hospital responsible for the care of all pediatric patients 
requiring open-heart surgery in Finland. The study was approved by the Ethics Committee 
(26.3.2015, 84/13/03/2015) and the Research Committee of the Children’s Hospital (approval 
§52/9.6.2015). 
All patients who underwent primary TCPC surgery between 1.1.2004 and 31.12.2014 were 
considered for the study. Re-operations were excluded from the dataset. Patients were 
retrospectively divided into two groups. The sildenafil group comprised all patients who 
received prophylactic sildenafil either preoperatively in the morning of the procedure or within 
24 hours after admission to the pediatric intensive care unit (PICU) (n=48). A total of 60 
patients, who did not receive sildenafil served as controls. Patients who were administered 
sildenafil later than 24 hours after the admission to PICU (n=14) were excluded from the 
study. Sildenafil was administered to patients according to the clinical judgment of surgeons 
and anesthesiologists. At that time of the study, no official guidelines for this specific question 
existed in our institution. The use of sildenafil quickly became a routine treatment in our 
institution in 2009 because of its theoretical advantages. 
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Operative procedure 
The management of anesthesia and cardiac surgery varied little during the study period. 
Anesthesia was induced with sufentanyl, pancuronium, and propofol and maintained by 
either propofol-infusion (6-10 mg/kg/h) or sevoflurane combined with sufentanyl-infusion (1-
2µg/kg/h). 
 
Blood flow during normothermic cardiopulmonary bypass (CPB) was 2.4 l/min/m2. Seventy-
two operations were performed with aortic cross clamping and thirty-six operations with a 
beating heart. The pump prime solution consisted of packed red cells, fresh frozen plasma, 
and albumin. The surgical technique for all the operations was the extracardiac conduit 
connection between the inferior vena cava and the pulmonary artery. In most patients 
(n=101) the size of the extracardiac conduit was 18mm. The decision to perform a 
fenestration of the TCPC pathway was at the discretion of the surgeon. The hematocrit was 
adjusted to 30% and increased during the rewarming by hemofiltration to between 35–40%, 
and by adding packed red cells as necessary. Continuous hemofiltration was used 
throughout the CPB when needed.  
 
Inotropic infusions were used to maintain adequate blood pressure and cardiac output. 
Milrinone was used as a first-line inotropic therapy at a median dose of 0.54µg/kg/min, 
whereas epinephrine or norepinephrine were used on an as-needed basis. There was no 
single standard blood pressure goal in our institution. A mean arterial pressure of 50 mmHg 
was mostly used as a cut-off for 3-4-year-old patients.  The vasoactive-inotropic score was 
calculated according to Gaies et al.7 
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Postoperative care 
Anesthesiologists were in charge of the treatments in the PICU. Cardiac surgeons and 
cardiologists were also actively involved in postoperative care as consultants. The treatment 
of hemorrhage and blood product administration was managed according to existing 
protocols with individual considerations. The limit for red blood cell transfusion was a 
hemoglobin level of 120 g/L. All patients were extubated in the PICU after warming, arousal 
from general anesthesia, hemodynamic stabilization and confirmation of minimal bleeding. 
Inhaled nitric oxide (iNO) was started in the operating room or the PICU at the discretion of 
the surgeon and the anesthesiologist in charge of the patient. All patients received 
furosemide, and most patients (n=87) received spironolactone. Patients were discharged to 
the cardiac ward after achieving adequate gas exchange, stable hemodynamics and without 
the need for other inotropes than milrinone. 
 
A single drain was removed in the ward if the effusion was insignificant. All the remaining 
drains were removed when the total pleural and peritoneal effusions reached less than 
3ml/kg/day. Drains were replaced according to clinical consideration in cases of symptomatic 
fluid accumulation. 
 
Data collection 
The primary outcome measure was the time to removal of drains, and the secondary 
outcome measures were the pleural and peritoneal effusions during the first POD and length 
of hospital and PICU stay. Multiple regression analysis was used to identify risk factors for 
prolonged effusion.  
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Perioperative data were manually collected from the anesthesia records and our institutional 
intensive care database (Centricity Critical Care Clinisoft; GE Healthcare, Chicago, Illinois, 
U.S.). Postoperative data was manually collected from both paper and electronic patient 
records in Helsinki University Hospital. Data from preoperative cardiac catheterizations 
performed during the preceding 6 months were also collected. Cardiac catheterization 
pressures were registered in the patient records at 1 mmHg accuracy. 
 
All deaths within 30 days of the operation were categorized as early deaths. For survival 
analyses, the last day of follow-up was 18.3.2016. End-points were death or heart 
transplantation. The date of death or transplantation was obtained from patient records, our 
national cardiac surgery database ProCardio, and the Finnish National Registry. All 
operations and follow-up were carried out at Helsinki Children’s Hospital, with a follow-up of 
100%. 
Statistical analyses 
Data are presented as n (%) for categorical data, mean ± standard deviation (SD) or median 
interquartile range (IQR) for continuous data. Normal distribution was tested using Shapiro-
Wilk test. The Mann-Whitney-U test was used for comparing distributions of two groups. P-
values of less than 0.05 were considered statistically significant. Multiple regression analysis 
was used for multivariable analysis. All statistical analyses were performed using SPSS 
Statistics (version 19.0, IBM Corp, Armonk, NY, U.S.). 
Results 
In total, 122 patients who underwent the TCPC operation between 2004 –2014 were 
considered for the study. Follow-up was complete (100%) for all patients. Forty-eight patients 
(39%) received sildenafil either preoperatively or within 24 hours of their admission to the 
PICU, and 60 patients (49%) did not receive sildenafil at any stage. Fourteen (11%) patients 
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who received sildenafil more than 24 hours from PICU admission were excluded from the 
study. 47 patients (78%) of the control group were operated before 31.7.2007. Until that, not 
a single patient of the sildenafil group was operated. Respectively 40 patients (83%) of the 
sildenafil group were operated after 1.5.2009, and not a single patient operated after that 
belonged to the control group. Approximately 20% of the patients were operated between 
1.8.2007-30.4.2009, at that time sildenafil quickly became a routine treatment. The median 
age of the 108 children who were included in the study was 3.2 [2.9-3.6] years. Mean 
sildenafil starting dose was 3.4 ± 1.2 mg/kg/day and it was continued at least until discharge 
from the hospital. For at least 33 patients of the sildenafil group, sildenafil was continued 
after discharge. Most baseline characteristics were comparable between the groups, 
including operative weight, preoperative mean pulmonary artery pressure (mPAP), oxygen 
saturation and the percentage of fenestrated TCPC operations (Table 1). Age (P = 0.013) 
and preoperative transpulmonary gradient (P = 0.004) were higher in the control group. No 
patients died within 30 days from the operation. Two patients, who did not receive sildenafil 
pre- or postoperatively died within a year of their operation (P = 0.149). No patients required 
heart transplantation within the first postoperative year. 
 
All patients had pleural drains, and 80 out of 108 patients had an ascites drain. The median 
amount of first-day pleural and peritoneal effusion was 78.8ml/kg/day. The median time to 
removal of drains did not differ significantly between the sildenafil and control group (11 [8–
19] vs. 11 [7–16] days respectively, P = 0.532). The relative amount of pleural and peritoneal 
effusion on the first POD and the length of stay in the PICU and hospital were also similar 
(Table 2). However, the median fluid balance on the first POD was significantly higher in the 
sildenafil group compared with controls (47 [12–103] vs. 7 [-6–67] ml/kg, P = 0.001).  
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We performed multiple regression analysis to recognize the potential predictors of a 
prolonged need for pleural drains. Variables included in the multivariable analysis were 
decided according to clinical reasoning and listed in Table 3. The first-day fluid balance in the 
PICU (95% confidence interval (CI) 0.015-0.094, P = 0.007; Table 3) and the use of iNO 
during the first POD (95% CI, 0.206-11.466, P = 0.042) were the only significant predictors of 
time from the operation to the removal of drains (Table 3). Patients who received iNO during 
the first POD produced larger amounts of effusions during the first POD, but they also had a 
longer duration of CPB (P = 0.014) and higher vasoactive-inotropic scores (P < 0.001) and 
serum lactate on admission to PICU (P = 0.026) even before the iNO was started. 
 
Discussion 
Sildenafil administration preoperatively or within 24 hours after a TCPC operation was 
associated with a significantly more positive fluid balance but did not shorten the time from 
the operation to the removal of the drains. 
 
Earlier studies on the effect of sildenafil have reported controversial findings. A retrospective 
study by Giordano et al. reported that sildenafil significantly reduced ascites and pleural fluid 
effusion, the need for vasoactive drugs, and shortened mechanical ventilation time.5 In 
contrast, a study by Mendoza et al. found that sildenafil and inhaled nitric oxide did not 
influence the duration of pleural effusion, mechanical ventilation, or the lengths of PICU or 
hospital stay.6 Sildenafil reduced pulmonary vascular resistance, but it also increased 
systemic vasodilatation, which may increase the need for postoperative fluid resuscitation. 
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In the current study, the first POD fluid balance in PICU and the use of iNO were the only 
factors associated with a significantly longer need for drains in the multivariable analyses. 
Patients administered iNO were sicker which prevents us from making any conclusions of the 
effect of iNO on outcomes. Previous studies reported that high intravenous fluid requirement 
during the first 24 postoperative hours after the TCPC procedure was an independent risk 
factor for increased pleural effusion and prolonged recovery.8,9 Excessive fluid resuscitation 
may damage the endothelial glycocalyx10 and thus increase vascular permeability and 
prolong the need for drains. Recently published TCPC management protocols such as the 
Portland and the Wisconsin protocols suggest that high dose diuretics prevent fluid 
accumulation. In these protocols supplemental oxygen is recommended for reducing 
pulmonary vascular resistance and sildenafil is not included.11–13  
 
Early extubation after the TCPC procedure has been associated with improved 
hemodynamics and shorter time to chest tube removal as the negative inspiratory 
intrathoracic pressure enhances pulmonary venous return.14,15 In the study by Giordano et al. 
mechanical ventilation times shortened simultaneously with the introduction of the new 
protocol and the use of sildenafil when compared to historical controls. The mean intubation 
time in the sildenafil group was 15.5 ± 4 hours and 23.3 ± 6 hours in the historical control 
group.5 Whether earlier extubation was due to the use of sildenafil or the awareness of the 
benefits of early extubation remains a question. Subsequent studies have not been able to 
reproduce these outcomes.6 In our study, the mean intubation time in the sildenafil group 
(19.6 ± 31.9 hours) and the control group (19.0 ± 27.0 hours) were both comparable with the 
control group of Giordano’s study. However, the effect of sildenafil on mechanical ventilation 
time is difficult to determine due to the presence of multiple confounding factors such as 
ventilator weaning protocols and PICU workload that might affect the extubation time. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Intravenous sildenafil reduced pulmonary artery pressure by about 10 % in infants 
undergoing cardiac surgery with slightly elevated pulmonary artery pressures.16 Also, 
sildenafil significantly reduced systemic blood pressure with systemic vasodilatation and 
deterioration in oxygenation, which was not improved by the administration of iNO. The 
deterioration in oxygenation most likely occurred due to an increase in intrapulmonary 
shunting due to sildenafil administration.16 There was no difference in the postoperative 
arterial saturation, central venous saturation, or lactate values between the groups in our 
data.  
 
In the present study milrinone, an ino-vasodilator, was used as first-line inotropic therapy for 
all the patients. Moreover, iNO was administered significantly more often to the sildenafil 
group than the control group. This effective reduction in the systemic vascular resistance and 
blood pressure after the TCPC operation was related to a significantly higher inotropic score 
on arrival at the PICU. It was also associated with increased fluid resuscitation leading to a 
significantly more positive fluid balance during the first and second POD. This combination 
therapy outweighed the possible beneficial effects of reduced normal pulmonary artery 
pressure to enhance pulmonary blood flow in patients after the TCPC operation. Liberal fluid 
administration associates with sildenafil, but the causal connection remains a question this 
study cannot answer. Many of the patients who received iNO also had substantial effusions 
and were hemodynamically unstable when placed on iNO. The significantly lower 
postoperative furosemide dose in the sildenafil group compared with the control group may 
be related to low blood pressure and the consequent decision to withhold the furosemide 
administration, although postoperatively blood pressure data were not collected in this study.  
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This was a pilot study to evaluate the effect of sildenafil on pleural effusion. TCPC protocols 
such as Portland or Wisconsin protocols that use fluid restriction without sildenafil seem to be 
rational.11–13 The next step would be to implement a similar protocol including early 
extubation within 6 hours14,15 in our institution and to collect data prospectively to detect the 
possible improvements in the outcome of this patient group.  
 
Limitations 
This study is a retrospective single center study and thus should be interpreted carefully. The 
study population was small, which reduces the statistical power of the study. However, the 
present study is larger than previous studies on sildenafil after the TCPC operation. Fourteen 
patients were excluded from the study because they didn’t match the definitions of either the 
control or sildenafil group. These patients received sildenafil later during their hospital stay 
when effusions had already increased. Patients in the sildenafil group were slightly younger 
because the control group included some patients on whom TCPC surgery was performed at 
an older age.  Data on the daily drainage amounts or fluid resuscitation for the whole hospital 
period could not be obtained for a small portion of the patients that underwent the TCPC 
operation. Daily albumin levels were not measured systematically. For completeness and 
comparison of follow-up data, we had to use the length of time to the removal of the drains. 
About 20% of patients in both groups were operated during the same era which makes these 
patients susceptible to selection bias. 
 
Conclusions 
Oral sildenafil administration preoperatively or within 24 hours after the TCPC operation had 
no positive effect on the clinical outcome.  
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Table 1. Demographic and preoperative data 
 Sildenafil 
group 
 N=48 
Control 
group 
 N=60 
P-value 
Age (years) 3.3 [2.9–3.8] 3.0 [2.7–3.5] 0.013a 
Sex (male) 24 (50%) 39 (65%) 0.118a 
Weight (kg) 14.5 [13.0–
15.6] 
13.9 [12.6–
15.3] 
0.395a 
Body surface area (m2) 0.61 [0.57–
0.65] 
0.59 [0.56–
0.63] 
0.149a 
Hemoglobin (g/l) 169 [163–178] 171 [164–
178]
0.573a 
Main cardiac defect    
  HLHS n (%) 27 (56%) 33 (55%) 0.897a 
  RV-hypoplasia 16 (33%) 23 (38%) 0.593a 
  Unbalanced AVSD 4 (8%) 4 (7%) 0.744a 
  Other UVH 1 (2%) 0 (0%) 0.264a 
Systemic ventricle (LV) 16 (33%) 24 (40%) 0.792a 
mPAP (mmHg) 10.5 [9.5–
11.5] 
11.0 [9.5–
11.5] 
0.543a 
SaO2 (%) 83 [80–86] 83 [80 – 86] 0.818a 
Transpulmonary gradient (mmHg) 4 [3.5–5] 5 [4 – 6] 0.004a 
End diastolic pressure (mmHg) 6 [4–8] 6 [5 – 7] 0.624a 
Data are presented as the number of subjects (%), median [interquartile range] 
aMann-Whitney-U test 
Abbreviations: AVSD, atrioventricular septal defect; HLHS, hypoplastic left heart syndrome; 
LV, left ventricle; mPAP, mean pulmonary artery pressure; RV-hypoplasia, hypoplasia of 
right ventricle; SaO2, arterial oxygen saturation; UVH, univentricular heart. 
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Table 2. Procedural and postoperative data 
 Sildenafil group 
 (N=48)  
Control group 
 (N=60)  
P-value  
Operation with fenestration 38 (83%) 54 (90%) 0.107a 
CPB time (min) 92 [66–121] 77 [55–115] 0.181a 
Operation with aortic cross 
clamping 
35 (73%) 37 (62%) 0.220a 
Aortic cross clamping time (min) 35 [17–56] 51 [22–67] 0.188a 
On the PICU admission    
  Vasoactive-inotropic-score 25 [18–32] 17 [12–24] <0.001a * 
  Central venous saturation (%) 67 [60–74] 64 [59–73] 0.421a 
  Lactate (mmol/l) 1.7 [1.2–2.0] 1.2 [1.0–1.6] 0.001a 
On the first POD at noon  
  Vasoactive-inotropic score 10 [5–18] 9 [6–17] 0.829a 
  Central venous saturation (%) 69 [61–76] 69 [61–74] 0.890a 
  SaO2 (%) 90 [86–94] 91 [87–96] 0.319a 
  Lactate (mmol/l) 2.0 [1.6–2.5] 2.1 [1.6–2.6] 0.620a 
  Hemoglobin (g/l) 147 [139–162] 153 [141–164] 0.290a 
Δhemoglobin (g/l) -22.7 ± 15.7 -19.8 ± 18.9 0.209a 
iNO during first 24 h 41 (89%) 36 (60%) 0.002a 
Ascites drainage loss in 0-24h 
(ml/kg/day) 
23 [0–45] 44 [1–80] 0.047a 
Pleural and mediastinal drainage 
loss in 0-24h (ml/kg/day) 
45 [33–70] 43 [33–52] 0.141a 
Total drainage loss in 0-24h 
(ml/kg/day) 
76 [45–122] 80 [53–132] 0.400a 
Fluid balance 24h after operation 
(ml/kg) 
47 [12–103] 7 [-6–67] 0.001a 
Ascites drainage loss in 24-48h 
(ml/kg/day) 
8.6 [0–19] 11 [0–24] 0.566a 
Pleural and mediastinal drainage 
loss in 24-48h (ml/kg/day) 
34 [23–49] 26 [19–48] 0.156a 
Total drainage loss in 24-48h 
(ml/kg/day) 
47 [30–60] 43 [21–57] 0.496a 
Fluid balance (cumulative in first 48 
h) (ml/kg) 
24 [-7–80] -12 [-47–14] <0.001a * 
Creatinine 48-72h after operation 
(µmol/l) 
26 [23–30] 28 [25–36] 0.038a 
Furosemide first POD (mg/kg) 0.72 [0.53–1.0] 1.1 [0.74–1.6] <0.001a * 
Spironolactone first POD (mg/kg) 1.9 [1.0–2.1] 1.6 [0.8–2.0] 0.306a 
Drain removal (days) 11 [8–19] 11 [7–16] 0.532a 
Intubation time (hours) 9.6 [5.5–20.4] 8.1 [5.5–19.3] 0.889a 
PICU stay (days) 4 [3–5] 4 [3–5] 0.578a 
Hospital stay (days) 17 [14–26] 16 [12–21] 0.323a 
Mortality (30 days) 0 0 1a 
Data are presented as the number of subjects (%), mean ± standard deviation or median 
[interquartile range] 
aMann-Whitney-U test 
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* P-value rounded up 
Abbreviations: CPB, cardiopulmonary bypass; Δhemoglobin, the difference between 
hemoglobin on the first POD and preoperative; iNO, inhaled nitric oxide; PICU, pediatric 
intensive care unit; POD, postoperative day; SaO2, arterial oxygen saturation. 
 
Table 3 Multiple regression analysis for the time of drains  
 P 95% CI β 
Systemic ventricle (LV) 0.144 -8.208-1.224 -0.172 
mPAP preoperatively 0.807 -1.239-0.968 -0.027 
Fenestration 0.836 -6.143-7.577 0.024 
Cardiopulmonary bypass time 0.768 -0.066-0.049 -0.033 
Sildenafil 0.283 -7.270-2.154 -0.129 
Hemoglobin on first POD 0.181 -0.042-0.220 0.144 
Mechanical ventilation time in PICU 0.932 -2.208-2.025 -0.011 
iNO during first 24h 0.042 0.206-11.466 0.243 
Fluid balance first 24h 0.007 0.015-0.094 0.368 
Vasoactive-inotropic score on first POD 0.351 -0.434-0.156 -0.141 
CI, confidence interval 
β, standardized coefficients 
Abbreviations: iNO, inhaled nitric oxide; LV, left ventricle; mPAP, mean pulmonary artery 
pressure; PICU, pediatric intensive care unit; POD, postoperative day.  
